Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Protective Role of DNA Repair Genes Against Acute Graft Versus Host Disease in Children

Patricia Huezo-Diaz, Chakradhara RS Uppugunduri, PhD, Mohamed Aziz Rezgui, MsC, Anuj Tyagi, PhD, Vid Mlakar, PhD, Laurence Lesne, MSc, Tiago Nava, MD, Yves Theoret, PhD, Yves Chalandon, MD PhD, Robbert Bredius, PhD MD, Jean-Hugues Dalle, MD PhD, Peter Bader, MD PhD, Christina Peters, MD, Henrique Bittencourt, MD PhD, Maja Krajinovic, MD PhD, Marc Ansari, MD

Blood (2017) 130 (Supplement 1): 749.

https://doi.org/10.1182/blood.V130.Suppl_1.749.749

Published: 2017

Journal Articles

KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia

Fida Khater, Mathieu Lajoie, Sylvie Langlois, Jasmine Healy, Sonia Cellot, Chantal Richer, Patrick Beaulieu, Pascal St-Onge, Virginie Saillour, Mark Minden, Monia Marzouki, Maja Krajinovic, Henrique Bittencourt, Daniel Sinnett

Blood (2017) 129 (12): 1729–1732.

https://doi.org/10.1182/blood-2016-10-744219

Published: 2017

Includes: Supplemental data

Journal Articles

Functional GSTA1 Haplotypes Affect Clearance and Toxicity of Busulfan When Administered in 16 Doses to Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Multicenter Prospective Study on Behalf of the Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2016) 128 (22): 665.

https://doi.org/10.1182/blood.V128.22.665.665

Published: 2016

Journal Articles

GSTA1 *B1a Haplotype Associated with Lower Busulfan Clearance in Conditioning before HSCT in Pediatric Patients

Tiago Nava, MD, Marc Ansari, MD, Yves Theoret, PhD, Mohamed Aziz Rezgui, Samira Mezziani, Marie-France Vachon, Michel Duval, MD, Henrique Bittencourt, MD PhD, Maja Krajinovic, PhD

Blood (2015) 126 (23): 3112.

https://doi.org/10.1182/blood.V126.23.3112.3112

Published: 2015

Journal Articles

GSTA1 Genotype Influences Performance of Initial Bu Prediction Methods during Conditioning before SCT

Tiago Nava, MD, Marc Ansari, MD, Yves Theoret, PhD, Mohamed Aziz Rezgui, Samira Mezziani, Marie-France Vachon, Michel Duval, MD, Maja Krajinovic, PhD, Henrique Bittencourt, MD PhD

Blood (2015) 126 (23): 4323.

https://doi.org/10.1182/blood.V126.23.4323.4323

Published: 2015

Journal Articles

Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric Prospective Study on Behalf of the Pediatric Disease Working Party of the European Blood and Marrow Transplantation Group

Blood (2014) 124 (21): 424.

https://doi.org/10.1182/blood.V124.21.424.424

Published: 2014

Journal Articles

Sulfolane (a metabolite of busulfan) Levels Could Predict Occurrence Of Hemorrhagic Cystitis In Children Receiving Busulfan Based Myeloablative Conditioning Before Hematopoietic Stem Cell Transplantation

Chakradhara Rao S Uppugunduri, Mohamed Aziz Rezgui, Yves Theoret, Patricia Huezo Diaz, PhD, Anuj Kumar Tyagi, PHD, Samira Mezziani, Marie-France Vachon, Catherine Desjean, Michel Duval, MD, Henrique Bittencourt, MD, Maja Krajinovic, MD, PhD, Marc Ansari, MD

Blood (2013) 122 (21): 4574.

https://doi.org/10.1182/blood.V122.21.4574.4574

Published: 2013

Journal Articles

Influence Of GST Gene Polymorphisms On Busulfan Pharmacokinetics and Outcome Of Hematopoietic Stem Cell Transplantation In Thalassemia Pediatric Patients

Marc Ansari, MD, Aziz Resgui, Patricia Huezo-Diaz, PhD, Sarah Marktel, MD, Michel Duval, MD, Henrique Bittencourt, MD, Barbara Cappelli, Maja Krajinovic, MD, PhD

Blood (2013) 122 (21): 2052.

https://doi.org/10.1182/blood.V122.21.2052.2052

Published: 2013

Journal Articles

Association Between Busulfan First-Dose Pharmacokinetics and Outcome in Children Receiving Myeloablative Busulfan-Based Conditioning Before Unrelated Umbilical Cord Blood Transplantation for Malignancies

Henrique Bittencourt, MD, Mohamed Aziz Rezgui, Samira Meziani, Marie-France Vachon, Catherine Desjean, Michel Duval, MD, Yves Theoret, Maja Krajinovic, Marc Ansari, MD

Blood (2012) 120 (21): 4143.

https://doi.org/10.1182/blood.V120.21.4143.4143

Published: 2012

Journal Articles

Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

Patricia Huezo-Diaz, PhD, Chakradhara Rao Uppungunduri, PhD, Anuj Kumar Tyagi, PhD, Mohamed Aziz Rezgui, MsC, Fabienne Gumy-Pause, MD, Michel Duval, MD, Henrique Bittencourt, MD, Maja Krajinovic, MD, Marc Ansari, MD

Blood (2012) 120 (21): 3025.

https://doi.org/10.1182/blood.V120.21.3025.3025

Published: 2012

Journal Articles

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia

Julie Rousseau, Vincent Gagné, Malgorzata Labuda, Cyrielle Beaubois, Daniel Sinnett, Caroline Laverdière, Albert Moghrabi, Stephen E. Sallan, Lewis B. Silverman, Donna Neuberg, Jeffery L. Kutok, Maja Krajinovic

Blood (2011) 118 (22): 5883–5890.

https://doi.org/10.1182/blood-2011-05-355560

Published: 2011

Includes: Supplemental data

Journal Articles

Myeloablative Conditioning with Pharmacokinetic-Targeted Intravenous Busulfan and Cyclophosphamide in Unrelated Cord Blood Transplantation for Myeloid Malignancies in Children

Henrique Bittencourt, MD, Marc Ansari, MD, Mohamed Aziz Rezgui, Samira Meziani, Marie-France Vachon, Catherine Desjean, Michel Duval, MD, Yves Théoret, Maja Krajinovic

Blood (2011) 118 (21): 1965.

https://doi.org/10.1182/blood.V118.21.1965.1965

Published: 2011

Journal Articles

Response: MRP4 gene polymorphisms and treatment response in adult ALL

Maja Krajinovic, Marc Ansari, Daniel Sinnett

Blood (2009) 114 (26): 5401–5402.

https://doi.org/10.1182/blood-2009-10-245175

Published: 2009

Journal Articles

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia

Marc Ansari, Géraldine Sauty, Malgorzata Labuda, Vincent Gagné, Caroline Laverdière, Albert Moghrabi, Daniel Sinnett, Maja Krajinovic

Blood (2009) 114 (7): 1383–1386.

https://doi.org/10.1182/blood-2008-11-191098

Published: 2009

Includes: Supplemental data

Journal Articles

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, François-Xavier Mahon

Blood (2008) 112 (5): 2024–2027.

https://doi.org/10.1182/blood-2008-03-147744

Published: 2008

Journal Articles

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

Stéphanie Dulucq, Geneviève St-Onge, Vincent Gagné, Marc Ansari, Daniel Sinnett, Damian Labuda, Albert Moghrabi, Maja Krajinovic

Blood (2008) 111 (7): 3692–3700.

https://doi.org/10.1182/blood-2007-09-110593

Published: 2008

Journal Articles

Polymorphisms in Multidrug Resistance-Associated Protein Genes Are Associated with Worse Outcome in Childhood Acute Lymphoblastic Leukemia.

Marc Ansari, MD, Geraldine Sauty, BSc, Albert Moghrabi, MD, Maja Krajinovic, MD, PhD

Blood (2007) 110 (11): 1443.

https://doi.org/10.1182/blood.V110.11.1443.1443

Published: 2007

Journal Articles

Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

Maja Krajinovic, Stéphanie Lamothe, Damian Labuda, Émilie Lemieux-Blanchard, Yves Théorêt, Albert Moghrabi, Daniel Sinnett

Blood (2004) 103 (1): 252–257.

https://doi.org/10.1182/blood-2003-06-1794

Published: 2004

Journal Articles

Polymorphism G 80 A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

Caroline Laverdière, Sonia Chiasson, Irina Costea, Albert Moghrabi, Maja Krajinovic

Blood (2002) 100 (10): 3832–3834.

https://doi.org/10.1182/blood.V100.10.3832

Published: 2002

Journal Articles

Susceptibility to Childhood Acute Lymphoblastic Leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 Genetic Polymorphisms

Maja Krajinovic, Damian Labuda, Chantal Richer, Sepideh Karimi, Daniel Sinnett

Blood (1999) 93 (5): 1496–1501.

https://doi.org/10.1182/blood.V93.5.1496

Published: 1999

NARROW

A Protective Role of DNA Repair Genes Against Acute Graft Versus Host Disease in Children

KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia

GSTA1 *B1a Haplotype Associated with Lower Busulfan Clearance in Conditioning before HSCT in Pediatric Patients

GSTA1 Genotype Influences Performance of Initial Bu Prediction Methods during Conditioning before SCT

Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric Prospective Study on Behalf of the Pediatric Disease Working Party of the European Blood and Marrow Transplantation Group

Sulfolane (a metabolite of busulfan) Levels Could Predict Occurrence Of Hemorrhagic Cystitis In Children Receiving Busulfan Based Myeloablative Conditioning Before Hematopoietic Stem Cell Transplantation

Influence Of GST Gene Polymorphisms On Busulfan Pharmacokinetics and Outcome Of Hematopoietic Stem Cell Transplantation In Thalassemia Pediatric Patients

Association Between Busulfan First-Dose Pharmacokinetics and Outcome in Children Receiving Myeloablative Busulfan-Based Conditioning Before Unrelated Umbilical Cord Blood Transplantation for Malignancies

Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia

Myeloablative Conditioning with Pharmacokinetic-Targeted Intravenous Busulfan and Cyclophosphamide in Unrelated Cord Blood Transplantation for Myeloid Malignancies in Children

Response: MRP4 gene polymorphisms and treatment response in adult ALL

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

Polymorphisms in Multidrug Resistance-Associated Protein Genes Are Associated with Worse Outcome in Childhood Acute Lymphoblastic Leukemia.

Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

Polymorphism G 80 A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

Susceptibility to Childhood Acute Lymphoblastic Leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 Genetic Polymorphisms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only